Par Health Recalls Brevital Sodium Injection Over Life-Threatening Particulate Matter

Par Health is voluntarily recalling two lots of Brevital® Sodium for Injection due to the presence of particulate matter, identified as cellulose. This recall, published by the FDA, addresses a serious safety concern as the particulate matter could lead to life-threatening adverse health consequences, including pulmonary emboli and blood vessel occlusions. The action aims to prevent severe patient harm.